Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors

Journal of Medical Virology

Volumn 80, Issue 10, 2008, Pages 1864-1867

  Kwon, So Yong ^a   Lim, A Hyun ^a   Ji, Young Park ^a   Seung, Hee Han ^b   Cho, Nam Sun ^a  

^a Korean Red Cross   (South Korea)

^b Seoul Dongbu Senior Care Center   (South Korea)

Author keywords

Blood donor; HTLV; Korea; Seroprevalence

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CHEMOLUMINESCENCE; CROSS REACTION; DNA SEQUENCE; FEMALE; HUMAN; IMMUNOASSAY; KOREA; MALE; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; SCREENING TEST; SEROLOGY; SEROPREVALENCE; T LYMPHOTROPIC VIRUS TYPE 1; T LYMPHOTROPIC VIRUS TYPE 2; VIRUS; WESTERN BLOTTING;

ADOLESCENT; ADULT; FEMALE; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HTLV-II ANTIBODIES; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; KOREA; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 50849097077     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21260     Document Type: Article

References (21)

1. Couroucé AM, Pillonel J, Lemaire JM, Maniez M, Brunet JB. 1993. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France. AIDS 7:841-847.
2. Donegan E, Lee H, Operskalski EA, Shaw GM, Kleinman SH, Busch MP, Stevens CE, Schiff ER, Nowicki MJ, Hollingsworth CG, Mosley JW, the Transfusion Safety Study Group. 1994. Transfusion transmission of retroviruses: Human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion 34:478-483.
3. Dow BC, Munro H, Ferguson K, Buchanan I, Jarvis L, Jordan T, Franklin IM, McClelland M. 2001. HTLV antibody screening using minipools. Transfus Med 11:419-422.
4. Kim TY. 2007. The outbreak of transfusion-transmitted HTLV infection by one blood donor with HTLV in Korea. Vox Sang 93:116.
5. Kim JM, Chang KH, Choi YH, Song YG, Kang SM, Yoon TY, Choi JM, Park SY, Lew DJ. 1999. Seroprevalence of HTLV-I in Cheju island, a Korean island adjacent to the endemic area of Japan. J AIDS 22:409-412.
6. Kleinman S, Swanson P, Allain JP, Lee H. 1993. Transfusion transmission of human T-lymphotropic virus types I and II: Serologic and polymerase chain reaction results in recipients identified through look-back investigations. Transfusion 31:14-118.
7. Lu SC, Kao CL, Chin LT, Chen JW, Yang CM, Chang JH, Hsu SC, Chang ACH, Chen BH. 2001. Seroprevalence and demographic characteristics of HTLV-I among blood donors in Taiwan: 1996-1999. Int J Hematol 74:333-337.
8. Manns A, Wilks RJ, Murphy EL, Haynes G, Figueroa JP, Barnett M, Hanchard B, Blattner WA. 1992. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 51:886-891.
9. Matsumoto C, Mitsunaga S, Oguchi T, Mitomi Y, Shimada T, Ichikawa A, Watanabe J, Nishioka K. 1990. Detection of human T-cell leukemia virus type I (HTLV-I) provirus in an infected cell line and in peripheral mononuclear cells of blood donors by the nested double polymerase chain reaction method: Comparison with HTLV-I antibody tests. J Virol 64:5290-5294.
10. Matsuoka M, Watanabe T, Kannagi M, Bangham C, Grassmann R, Marriott SJ, Green P, Jeang KT. 2007. Meeting report on the 13th international conference on human retrovirology: Human T-cell leukemia virus research 30 years after adult T-cell leukemia. Cancer Res 67:10638-10641.
11. Okochi K, Sato H, Hinuma Y. 1984. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: Seroconversion in recipients. Vox Sang 46:245-253.
12. Pawson R, Mufti GJ, Pagliuca A. 1998. Management of adult T-cell leukaemia/lymphoma. Br J Haematol 100:453-458.
13. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL. 2005. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24:6058-6068.
14. Saito M, Moritoyo T, Park JH, Lee BI, Kim JS, Fujisawa J, Osame M, Yoshida M. 1993. Nucleotide sequence analysis of HTLV-I isolate from a Korean patient with HAM/TSP. Yonsei Med J 34:321-327.
15. Seiki M, Hattori S, Hirayama Y, Yoshida M. 1983. Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci 80:3618-3622.
16. Stigum H, Magnus P, Samdal HH, Nord E. 2000. Human T-cell lymphotropic virus testing of blood donors in Norway: A cost-effect model. Int J Epidemiol 29:1076-1084.
17. Stramer SL, Foster GA, Dodd RY. 2006. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004. Transfusion 46:703-707.
18. Tynell E, Andersson S, Lithander E, Arneborn M, Blomberg J, Hansson HB, Krook A, Nomberg M, Ramstedt K, Shanwell A, Bjorkman A. 1998. Screening for human T cell leukemia/lymphoma virus among blood donors in Sweden: Cost effectiveness analysis. Br Med J 316:1417-1422.
19. Vandamme AM, Van Laethem K, Liu HF, Van Brussel M, Delaporte E, de Castro Costa CM, Fleischer C, Taylor G, Bertazzoni U, Desmyter J, Goubau P. 1997. Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology. J Med Virol 52:1-7.
20. Vrielink H, Van der Poel CL, Reesink HW. 1995. Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodies. Vox Sang 68:251-252.
21. Yamaguchi K. 1994. HTLV-I in Japan. Lancet 343:213-215.